US Patent Issued to King Faisal Specialist Hospital & Research Centre on May 13 for "TTP phosphorylation for the identification of personalized medicines" (Saudi Arabia Inventor)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,955, issued on May 13, was assigned to King Faisal Specialist Hospital & Research Centre (Riyadh, Saudi Arabia).

"TTP phosphorylation for the identification of personalized medicines" was invented by Khalid S. Abu Khabar (Riyadh, Saudi Arabia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of determining if a patient is likely to respond to a treatment with a targeted therapy compound selected from protein kinase inhibitors, small molecule inhibitors, and monoclonal antibody-based compounds. The present invention further relates to a method of identifying a targeted therapy compound selected from protein kina...